CSF3 and neoplasm: A few studies recommend G-CSF administration to enhance the tumor-specific cytotoxicity of chemotherapy [29,30], to allow dose intensification of chemotherapy [31-33] with low myelotoxicity and mucosal toxicity levels [31].